FDA Passes On Critical Limb Ischemia Laser; Spectranetics Ponders Options
This article was originally published in The Gray Sheet
Executive Summary
Spectranetics hopes FDA will accept a retrospective analysis of bypass surgery data as a control arm to support a critical limb ischemia indication for its CVX-300 excimer laser catheter system in lieu of further clinical studies